Matthew Ros, See Remarks at Epizyme, Inc. (EPZM), sold 221,717 shares at $21.65 ($4.7M) on 2020-06-18, disclosed to the SEC on 2020-06-22.
Open-market sale of $4.7M EPZM by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.50 | 41,063 | $842K | 17.9% |
| 2 | $20.50 | 41,063 | $842K | 17.9% |
| 3 | $21.65 | 68,651 | $1.5M | 31.6% |
| 4 | $21.65 | 68,651 | $1.5M | 31.6% |
| 5 | $22.00 | 2,289 | $50K | 1.1% |
| Total | $21.23 avg | 221,717 |
| $4.7M |
| 100% |
| Filing → |
| EPZM | SELL | 2020-06-30 | $44K | — | Filing → |
| EPZM | SELL | 2020-03-26 | $19K | — | Filing → |
| EPZM | SELL | 2020-01-27 | $46K | — | Filing → |